ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

18,841Medicare Part D Prescriptions Filled, Including Refills
$895K Total Retail Price of All Prescriptions
450 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 1,235 1,078 S3
FUROSEMIDE 746 662
LEVOTHYROXINE SODIUM 734 687
POTASSIUM CHLORIDE 531 509
CYMBALTA 456 397
METOPROLOL TARTRATE 442 401
WARFARIN SODIUM 422 346
GABAPENTIN 404 337
AMLODIPINE BESYLATE 401 378
SIMVASTATIN 306 260
LISINOPRIL 288 238
QUETIAPINE FUMARATE 280 246
SERTRALINE HCL 259 243
MIRTAZAPINE 242 224
CITALOPRAM HBR 233 192
JANTOVEN 204 192
MORPHINE SULFATE ER 201 121 S2
DIVALPROEX SODIUM 200 179
RISPERIDONE 195 138
METFORMIN HCL 191 156
SPIRONOLACTONE 188 166
BENAZEPRIL HCL 184 149
LACTULOSE 166 117
BACLOFEN 159 106
CLOPIDOGREL 151 141
NAMENDA 150 148
SEROQUEL 150 135
OMEPRAZOLE 147 122
FENTANYL 143 112 S2
OXYCODONE-ACETAMINOPHEN 143 140 S2
ENALAPRIL MALEATE 139 137
TAMSULOSIN HCL 139 116
LEVOFLOXACIN 135 112
DONEPEZIL HCL 135 135
TRAZODONE HCL 135 124
IPRATROPIUM-ALBUTEROL 133 119
SPIRIVA 130 116
CIPROFLOXACIN HCL 129 107
DIGOXIN 128 112
LEVEMIR 126 116
MORPHINE SULFATE 123 105 S2
KLOR-CON M10 118 98
METOPROLOL SUCCINATE 117 116
CARVEDILOL 117 101
POLYETHYLENE GLYCOL 3350 116 83
PLAVIX 107 106
ADVAIR DISKUS 104 86
AZITHROMYCIN 103 87
OXYCODONE HCL 101 74 S2
EXELON 99 98
PREDNISONE 98 89
CARBIDOPA-LEVODOPA 97 95
NYSTATIN 96 83
NOVOLOG 96 85
PROMETHAZINE HCL 93 76 R
HYDRALAZINE HCL 93 86
PRAVASTATIN SODIUM 91 91
SANTYL 90 68
NOVOLOG FLEXPEN 90 78
DILTIAZEM HCL 87 86
DILTIAZEM ER 85 75
ALLOPURINOL 83 63
DIOVAN 82 82
GLIMEPIRIDE 81 79
PANTOPRAZOLE SODIUM 80 70
PAROXETINE HCL 78 52
ATENOLOL 77 46
CLONIDINE HCL 77 66
HYDROCHLOROTHIAZIDE 75 70
LEVETIRACETAM 75 53
OXYCODONE HCL-ACETAMINOPHEN 75 74 S2
ESCITALOPRAM OXALATE 75 71
BUMETANIDE 67 65
HYDROXYZINE HCL 66 64 R
DILTIAZEM 24HR CD 64 64
ALBUTEROL SULFATE 63 59
NEXIUM 63 36
FAMOTIDINE 62 39
LANTUS 62 52
ISOSORBIDE MONONITRATE ER 61 60
TRAMADOL HCL 60 40
PHENYTOIN SODIUM EXTENDED 60 36
CEFTRIAXONE 59 56
LEVEMIR FLEXPEN 59 54
FLUOXETINE HCL 58 56
OLANZAPINE 58 57
ABILIFY 57 57
DETROL LA 57 48
GLYBURIDE 57 55 R
KADIAN 57 57 S2
NIFEDIPINE ER 56 42
NITROFURANTOIN MONO-MACRO 55 48
ATORVASTATIN CALCIUM 54 47
LOVASTATIN 53 50
SINGULAIR 52 48
LIDOCAINE HCL 52 48
AMIODARONE HCL 51 50
LOSARTAN POTASSIUM 51 50
LYRICA 50 47
HALOPERIDOL 50 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.